Loading…
The ectonucleotide pyrophosphatase phosphodiesterase 1 ( ENPP1) K121Q polymorphism modulates the beneficial effect of weight loss on fasting glucose in non-diabetic individuals
Abstract Background and aims Several studies have reported that the ectonucleotide pyrophosphatase phosphodiesterase 1 ( ENPP1) K121Q polymorphism (rs1044498) interacts with increased adiposity in affecting glucose homeostasis and insulin sensitivity. Conversely, one would expect that the ameliorati...
Saved in:
Published in: | Nutrition, metabolism, and cardiovascular diseases metabolism, and cardiovascular diseases, 2013-06, Vol.23 (6), p.505-510 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Abstract Background and aims Several studies have reported that the ectonucleotide pyrophosphatase phosphodiesterase 1 ( ENPP1) K121Q polymorphism (rs1044498) interacts with increased adiposity in affecting glucose homeostasis and insulin sensitivity. Conversely, one would expect that the amelioration of glucose homeostasis observed after weight loss is modulated by the ENPP1 K121Q polymorphism. The aim of our study was to test such hypothesis, in non-diabetic overweight-obese individuals. Methods and results Two hundred eleven non-diabetic overweight-obese individuals were studied. Body mass index (BMI), fasting glucose, homeostasis model assessment of insulin resistance (HOMA-IR index) and lipid levels were obtained before and after 6-week lifestyle intervention (LI; diet and exercise) and their changes calculated as baseline minus 6-week values. LI decreased BMI, glucose, HOMA-IR and triglyceride levels ( p |
---|---|
ISSN: | 0939-4753 1590-3729 |
DOI: | 10.1016/j.numecd.2011.11.003 |